BIS

ProShares UltraShort Nasdaq Biotech
NASDAQ

Real-time Quotes | Provided by Morningstar

31.55
-0.35
-1.08%
Opening 13:00 09/23 EDT
OPEN
32.10
PREV CLOSE
31.89
HIGH
32.27
LOW
31.46
VOLUME
19.66K
TURNOVER
--
52 WEEK HIGH
85.80
52 WEEK LOW
27.84
TOTAL ASSET
12.58M
YTD YIELD
-35.86%
1D
5D
1M
3M
1Y
5Y
News
Performance
UCO, GUSH, LABU and SCO among weekly ETF movers
Gainers: S&P Biotech Bull 3X Direxion (LABU) +35.9%.Pharmaceutical & Medical Bull 3X Direxion (PILL) +15.9%.Ultra DJ-UBS Crude Oil Proshares (UCO) +14.0%.Ultra Nasdaq Biotech Proshares (BIB) +13.3%.S&P Oil & Gas Expl Bull 3X Direxion (GUSH) +13.2%.Losers: S&P Biotech
Seekingalpha · 4d ago
Investors Buying the Dip Pour Billions Into Two Nasdaq Funds
Bloomberg · 09/08 12:27
Hedge Fund’s Buying Spree During Credit Slump Fuels 36% Return
Distressed-assets specialist Alp Ercil went on a billion-dollar buying spree in March and April, bargain-hunting amid the indiscriminate selloff in credit markets, a person familiar with the matter said.
Bloomberg · 09/06 21:00
UGAZ, UCO, LABU and SCO among weekly ETF movers
Seeking Alpha - Article · 06/19 21:35
ACADIA Pharmaceuticals: The Worst-Case Scenario For Investors
Seeking Alpha - Article · 06/08 00:01
Dems attack Trump over stalled efforts to lower drug prices
Seeking Alpha - Article · 02/21 14:32
Drugmakers getting creative over ways to pay for pricey meds
Seeking Alpha - Article · 01/13 17:16
California mulling private-label generics to address high drug costs
Seeking Alpha - Article · 01/09 15:05
More
No Data
Learn about the latest financial forecast of BIS. Analyze the recent business situations of ProShares UltraShort Nasdaq Biotech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Month
11.9342%
--
3-Month
-1.3857%
--
6-Month
-38.6393%
--
1-Year
-35.8612%
--
3-Year
-24.4350%
--
5-Year
-22.8571%
--
10-Year
-39.5661%
--
Since Inception
-37.6429%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
ProShares UltraShort Nasdaq Biotech
Risk
Low risk
Inception Date
2010-04-06
Benchmark
Russell 1000 Growth TR
Advisor Company
ProShares
Custodian
JPMorgan
Manager
Neches/Dave